Healwell AI Secures Major State-Level U.S. Contract, Shares Surge

Healwell AI secures a multi-million dollar US state HIE deal, driving a 19.23% stock surge. The win marks a key step in its SaaS pivot and international expansion.

The digital health company Healwell AI has successfully secured a multi-year, multi-million dollar agreement with a government-operated health network in the United States. This significant contract win triggered an immediate and positive reaction in the financial markets, with the company's stock price experiencing a substantial single-day increase.

Market Reaction and Financial Performance

Trading on the Toronto Stock Exchange (TSX), Healwell AI's equity saw a dramatic uptick following the announcement. The share price advanced by CAD $0.15, representing a gain of 19.23 percent, to close at CAD $0.93. Trading activity was notably high, with more than 1.1 million shares changing hands, positioning the stock among the exchange's top performers for the day.

Details of the Landmark Agreement

The company announced the contract victory on March 5, 2026. Healwell AI prevailed in a competitive bidding process to be selected as the provider. Through its subsidiaries, Orion Health and VeroSource, the firm will develop and implement a comprehensive Health Information Exchange (HIE) platform for an entire U.S. state.

This secure system is designed to aggregate and facilitate the exchange of sensitive patient data across numerous healthcare entities, including hospitals, clinics, laboratories, and government agencies. The technology integrates directly with existing clinical systems, granting physicians real-time access to critical information such as admission, discharge, and transfer notifications, lab results, and treatment reports. The primary objectives are to enhance care coordination, eliminate redundant testing, and provide clinicians with a more complete patient history.

Strategic Pivot and Growth Trajectory

This U.S. deal is the latest in a string of international expansions for Healwell AI, underscoring a strategic shift towards becoming a pure-play software-as-a-service (SaaS) provider focused on large-scale health systems and enterprise clients.

• Recent International Wins: In late February, the company announced its first artificial intelligence contract in the Middle East. It also reported further deployments of its SMART product suite—SMART Identify, SMART Search, and SMART Summary—within additional Canadian and American healthcare systems.
• Product Launches and Pipeline: Earlier in February, Healwell AI partnered with WELL Health to launch the WELLTRUST™ platform. This system empowers patients with control over their health data and utilizes Healwell's DARWEN™ AI engine to identify suitable candidates for clinical trials without compromising data privacy or compliance. The company is also preparing for the North American launch of its Amadeus AI solution in the first half of 2026, with an international rollout to follow.
• Strategic Significance: Management reports robust growth in its software pipeline, driven by both renewals from existing customers and new bids across Canada, the Middle East, and Europe. The newly won state-level contract in the U.S. provides a powerful reference case that is expected to carry significant weight in future large-scale tender processes.

For investors, this contract serves as a tangible signal that Healwell AI's international growth strategy is gaining traction and that the market is willing to pay for its specialized digital health solutions.